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ABSTRACT 
Confocal laser endomicroscopy (CLE) is an advanced optical fluorescence imaging technology 
that has potential to increase intraoperative precision, extend resection, and tailor surgery for 
malignant invasive brain tumors because of its subcellular dimension resolution. Despite its 
promising diagnostic potential, interpreting the gray tone fluorescence images can be difficult for 
untrained users. CLE images can be distorted by motion artifacts, fluorescence signals out of 
detector dynamic range, or may be obscured by red blood cells, and thus interpreted as 
nondiagnostic. However, just a single CLE image with a detectable pathognomonic histological 
tissue signature can suffice for intraoperative diagnosis. Dealing with the abundance of images 
from CLE is not unlike sifting through a myriad of genes, proteins, or other structural or 
metabolic markers to find something of commonality or uniqueness in cancer that might indicate 
a potential treatment scheme or target. In this review we provide a detailed description of 
bioinformatical analysis methodology of CLE images that begins to assist the neurosurgeon and 
pathologist to rapidly connect on-the-fly intraoperative imaging, pathology, and surgical 
observation into a conclusionary system within the concept of theranostics. We present an 
overview and discuss deep learning models for automatic detection of the diagnostic CLE 
images and discuss various training regimes and ensemble modeling effect on power of deep 
learning predictive models. Two major approaches reviewed in this paper include the models that 
can automatically classify CLE images into diagnostic/nondiagnostic, glioma/nonglioma, 
tumor/injury/normal categories and models that can localize histological features on the CLE 
images using weakly supervised methods. We also briefly review advances in the deep learning 
approaches used for CLE image analysis in other organs. Significant advances in speed and 
precision of automated diagnostic frame selection would augment the diagnostic potential of 
CLE, improve operative workflow and integration into brain tumor surgery. Such technology and 
bioinformatics analytics lend themselves to improved precision, personalization, and theranostics 
in brain tumor treatment. 
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Introduction 
 
According to the American Cancer Society
1
, in 2018 nearly 24,000 patients will be diagnosed 
with brain or other nervous system cancer and about 17,000 patients will die of the disease. 
Gliomas represent about 25% of all primary brain tumors and about 80% of all malignant tumors 
of the central nervous system
2
. Over half of gliomas are glioblastoma multiforme (GBM), which 
is the most malignant primary brain tumor. GBMs are infiltrative and normally lack a clear 
margin making complete resection nearly impossible. Maximal resection of gliomas has been 
associated with improved prognosis
3,4
, although invasion and the bounds of functional cortex 
often limit extensive removal. Currently, technology for extending the limits of the tumor 
resection relies on intraoperative image-guided surgical navigation platforms, intraoperative 
magnetic resonance imaging (MRI), and intraoperative ultrasound
5
. Wide-field fluorescence 
illumination through the operative microscope has been utilized more recently in an attempt 
identify the margins of infiltrating tumors
6
. 
 
Regardless of the means for identifying the tumor margin, examining tissue samples during 
surgery is paramount, especially for neurosurgery. Rapid intraoperative assessment of tumor 
tissue remains key for planning the treatment and for guiding the surgeon to areas of suspected 
tumor tissue during the operation, or planning adjunct intraoperative or post-operative therapy. 
The standard for the preliminary intraoperative histopathological interpretation is frozen section 
biopsy. However, the frozen section biopsy method has inherent complications such as sampling 
error, tissue freezing and cutting artifacts, lack of immediate pathologist interactivity with the 
surgeon, time spent for tissue delivery, processing, and analysis reporting back to the operating 
room
7,8
. 
 
Handheld (i.e., size of a pen), portable confocal laser endomicroscopy (CLE) is undergoing 
exploration in brain tumor surgery because of its ability to produce precise histopathological 
information of tissue with subcellular resolution in vivo in real time during tumor resection 
8ߞ13
. 
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CLE is a fluorescence imaging technology that is used with a combination with fluorescent drugs 
or probes. While a wide range of fluorophores have been used for CLE in gastroenterology and 
other medical specialties, fluorophore options are limited for in vivo human brain use due to 
potential toxicity
8,9,11,14
. Fluorescent dyes currently approved for use in vivo in the human brain 
include fluorescein sodium (FNa), indocyanine green (ICG), and 5-aminolevulinic acid (5-
ALA)
9,15,16
. Other fluorescent dyes such as acridine orange (AO), acriflavine (AF), cresyl violet, 
etc., can be used on human brain tissue ex vivo
12,17
. In neurosurgical oncology, CLE has been 
used to rapidly obtain optical cellular and cytoarchitectural information about tumor tissue as the 
resection progresses and to interrogate the resection cavity
12,13
. The details of system operation 
have been previously described in detail
8,12,13,18
. Briefly, the neurosurgeon may hold the CLE 
probe by the hand, fixate it with a flexible instrument holder in place, or may glide the probe 
across the tissue surface to obtain an ߧoptical biopsyߨ with an image acquisition speed ranging 
between 0.8 and 20 frames per second dependent on operation of the particular CLE system. The 
surgeon may place the probe in a resting position at any time and proceed with the tumor 
resection, then take up the probe conveniently as desired. CLE imaging is believed to be 
potentially advantageous for appraisal of tumor margin regions or to examine suspected invasion 
into functional cortex near the final phases of tumor resection. The images display on a 
touchscreen monitor attached to the system. The neurosurgeon uses a foot pedal module to 
control depth of scanning and image acquisition. An assistant can also control the acquisition of 
images using a touchscreen. CLE images can be processed and presented as still images, digital 
video loops showing motion, or 3-dimensional digital imaging volumes. CLE is a promising 
technology with the strategy to optimize or maximally increase the resection of malignant 
infiltrating brain tumors and/or to increase the positive yield of tissue biopsy. CLE may be of 
especial value during surgery when interrogating tissue at the tumor border regions or within the 
surgical resection bed that may harbor remnant malignant or spreading tumor.  
 
Cancer is the subject of intense investigation into how theranostics may improve care and 
survival. As oncology is continually refined in its quest to understand and treat malignant brain 
tumors, such as GBMs, with which it has had very little success, utilization of precision and 
personalized surgical techniques would seem to be a logical step forward, especially as tumor 
resection is usually the first definitive treatment step. Dealing with the abundance of images 
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from CLE is not unlike sifting through a myriad of genes, proteins, or other structural or 
metabolic markers to find something of commonality or uniqueness in cancer that might indicate 
a potential treatment scheme or target. CLE data acquisition is vast, burdened with a near-
overwhelming number of images, many of which appear not useful at first inspection, although 
they may have unrecognized informative image subregions or characteristics. Mathematical 
algorithms and computer-based technology may rapidly assist making decisions upon an 
incredible number of images, such as CLE produces, that has never been encountered in 
neurosurgery. 
 
Critical success in theranostics relies on the analytical method. Finding meaning can be elusive, 
and what may seem at first meaningful may only be superficial or even a spurious result, thus the 
analytical methodology is critical. In this review we provide a detailed description of 
bioinformatical analysis methodology of CLE images that begins to assist the neurosurgeon and 
pathologist to rapidly connect on-the-fly intraoperative imaging, pathology, and surgical 
observation into a conclusionary system within the concept of theranostics. We describe 
methodology of deep convolutional neural networks (DCNNs) applied to CLE imaging focusing 
on neurosurgical application and review current modeling outcomes, elaborating and discussing 
studies aiming to suggest a more precise and tailored surgical approach and workflow for brain 
tumor surgery.  
 
Demanding imaging information load of confocal laser endomicroscopy 
 
Although the number of non-diagnostic CLE images has been shown to be high, the first 
diagnostic frames were acquired at an average after the 14th frame (about 17 sec) in vivo
12
. This 
is certainly faster than for an intraoperative frozen section biopsy preparation and diagnostic 
interpretation. Nevertheless, the high number of non-diagnostic images imposed a significant 
time requirement and image storage load for subsequent image reviews, leading us and other 
groups to employ deep learning algorithms and neural networks that could potentially sort out 
non-diagnostic frames, while retaining only the diagnostic ones
19,20
. Attempts to use advanced 
feature coding schemes to classify cellular CLE images of brain tumor samples stained ex vivo 
with AF have been reported
21
. Advantageously, acquired CLE images may be exchanged and 
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translated for off-site digital histopathology review. However, large amounts of data may create 
an information overload that requires novel solutions for data CLE management and storage.  
 
While CLE has obvious benefits of rapid on-the-fly digital imaging of tissue that can obviate 
long wait times for tissue interpretation and be quickly communicated between surgeons and 
pathologists, there are challenges to manage the amount of information provided. Current CLE 
systems can generate hundreds to thousands of images over the course of examination of the 
tumor or resection cavity which may take only a few minutes. It has been estimated that since 
CLE technology was put into use in 2011 for gastrointestinal diagnosis, over 100 million images 
have been created, with 30 million images created in the past year
22
. The number of images may 
become rapidly overwhelming for the neurosurgeon and neuropathologist when trying to review 
and select a diagnostic or meaningful image or group of images as the surgical inspection 
progresses. CLE is designed to be used in real time while the surgeon operates on the brain, but 
overcoming the barriers of image selection for diagnosis is a key component for making CLE a 
practical and advantageous technology for the neurosurgical operating room. 
 
Other barriers for revealing underlying meaningful histology are motion and blood artifacts 
(especially) that are present in some of the CLE images, especially for CLE systems functioning 
in the blue laser range versus near-infrared
8,9,12,23,24
. In addition, the neuropathologist must begin 
to work in a world of fluorescence images showing shades of gray, black and white or artificial 
colorization, where before natural colored stains existed.  The display of suboptimal 
nondiagnostic frames interferes with the selection of and focus upon diagnostic images by the 
neurosurgeon and pathologist throughout the surgery to make a correct intraoperative 
interpretation. A previous study of CLE in human brain tumor surgeries found that about half of 
the acquired images were interpreted as nonuseful (i.e., nondiagnostic) due to an inherent nature 
of the handheld microscopic probe with a narrow field of view that is subject to motion and 
blood artifacts or lack of discernible or characteristic features of the tissue itself
12
. These artifacts 
or inherent aspects of operation of the probe include unsteady hand movements, moving the 
probe while in imaging mode across the tissue surface, and irregularities of the tissue surface 
such as a tumor resection bed in the cortex that includes tissue crevices, surface irregularities, 
bleeding, movement of the cortex with arterial pressure and respiration, etc.  
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Thus, although imaging is acquired on-the-fly, an image discrimination system to optimally sift 
out and identify useful images would substantially improve the performance of the CLE.  
Manually filtering out the nondiagnostic images before making an intraoperative decision is 
challenging due to the large number of images acquired, the novel and frequently unfamiliar 
appearance of fluorescent stained tissue features compared to conventional histology. 
Interpretation of fluorescence CLE images for routine clinical pathology has only recently been 
trained and studied. Great variability among images from the same tumor type, and potential 
similarity between images from other tumor types for the untrained interpreter (Figure 1) make 
simple image filters and thresholding unreliable, thus requiring advanced computational 
methods.  
Theranostics and confocal laser endomicroscopy 
 
Investigations into cancer genetics have produced treatment pathways by the application of 
bioinformatics methods leading to the concept of theranostics. As advances in molecular science 
have enabled ߧfingerprintingߨ of individual tumor with genomic and proteomic profiling, 
personalized theranostic agents can be developed to target specific tumor microenvironment 
compartments
25
. Although theranostic imaging provides new opportunities for personalized 
cancer treatment through the interface of chemistry, molecular biology, and imaging, quantitative 
image analysis remains as one of its challenges
26
. More sophisticated image analysis methods are 
required to visualize and target every aspect of the tumor microenvironment in combination with 
molecular agents
27
. CLE technology potentially allows a more personalized, precise, or tailored 
approach to the surgical procedure to remove an invasive brain tumor because of its capability to 
image at cell resolution intraoperatively on-the-fly. Fluorescent stains or markers allow the 
imaging and potential targeting of cells ߞ nearly we are at the surgery of the ߧcellߨ as specific 
stains or fluorescent markers are developed. Whether, this technology has practicality or yields 
survival benefit for malignant invasive brain tumors awaits the results of the first substantial in 
vivo explorations.  
 
Deep learning application in CLE brain tumor diagnostics 
 
Deep convolutional neural networks (DCNNs) are a subset of ߧdeep learningߨ technology, a 
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machine learning subfield that has achieved immense recognition in the field of medical image 
analysis. Advances in computer-aided detection (CADe) and diagnosis (CADx) systems in 
ultrasound, magnetic resonance imaging, and computed tomography (CT) have been reviewed 
previously
28
. There have been only a few studies that investigated deep learning application to 
enhance the diagnostic utility of CLE imaging in brain tumors. The utilization of deep learning 
approaches is mainly focused around three goals: diagnostic image detection, tumor 
classification, and feature localization originating from image segmentation. Here we provide an 
overview of the basics of a deep learning methodology applicable to CLE images, summarize 
current results of brain tumor CLE image analysis using DCNNs, and juxtapose these with 
related works in other cancers. 
 
A deep convolutional neural network (DCNN) consists of several layers, each having multiple 
units called feature maps
29
. The first layer includes the input images that will be analyzed. To 
produce the second layer’s feature maps, each pixel of layer 2 is connected to a local patch of 
pixels in layer 1 through a filter bank followed by an activation function, which is usually a 
rectified linear unit (ReLU) because of its fast-to-compute property compared to other 
functions
30
. Model parameters are learned by minimizing the loss (the error between model 
prediction and the ground truth) using an optimization algorithm in two steps: forward and 
backward propagations
31,32
. To adjust the weights of filter banks, after each iteration of forward 
propagating the network, the derivatives of the loss function with respect to different weights are 
calculated to update the weights in a backward propagation
32
. A pooling layer accumulates the 
features in a smaller region by replacing windows of a feature map with their maximum or the 
average value. By stacking several convolutional, pooling, and fully connected layers, a DCNN 
can learn a hierarchy of visual representations to recognize class-specific features in images
29
. 
Figure 2 shows an example network architecture and how the feature maps are calculated to 
perform diagnostic brain tumor image classification.  
 
The validity of recommendations resulted from the DCNN analysis greatly depends upon the 
ground truth established by the expert professional. Unlike other conventional surgical tissue 
examination modalities like hematoxylin and eosin (H&E) stained histopathological slides, the 
CLE images are novel to neuropathologists and neurosurgeons. Since the beginning of CLE 
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investigation in brain tumor surgery, the ground truth was established by surgical biopsy and 
subsequent standard histopathology analysis acquired from the same location as the CLE "optical 
biopsy" and correlating the features on CLE images to the histopathological sections. 
Neuropathologists and neurosurgeons at a few select centers are correlating CLE features to 
histopathology in order to establish an expertise in reading CLE images, and such investigations 
are ongoing
10,12,18
. The experience in CLE image interpretation is imperative for meaningful 
DCNN analysis. However, as described later, delving deeper into the DCNN analysis of the CLE 
while using ground truth established by the standard histopathology, results in identification of 
novel CLE features and allows many more images that may be termed suboptimal to in fact 
become useful. The improvement in workflow and diagnostics, and thus theranostics in CLE, 
will be dependent upon robust computer learning architecture. 
 
Tumor classification 
 
One of the first deep learning approaches for making a diagnosis of a brain tumor type based on 
the CLE images was a cascaded deep decision network (DDN), a type of DCNN
33
. A network 
was trained for classification of glioma and meningioma images using their previously proposed 
multi-stage DDN architecture
34
 for developing the model. The training process was as follows: 
LeNet, a relatively shallow CNN architecture initially proposed by LeCun, et al.
35
 for 
handwritten digit recognition, was trained on the training dataset until it produced descent 
classification results on validation images. Then, the images were divided into two categories: 
easy images (classified correctly by the model with high confidence) and challenging images 
(classified either wrongly or even correctly yet with a low confidence). The challenging images 
were passed to the next stage for retraining. In the second stage, a convolutional stage and two 
fully connected layers and a softmax layer were stacked to the previous network and trained, 
while freezing the previous layers' parameters. After training the second stage on the challenging 
images from stage 1, the same process was repeated (finding confidence threshold, filtering the 
easy images, passing the challenging images to next stage, stacking the new layers to the 
previous network) until the model fails to improve on the validation dataset. After removing 
uninformative images using image entropy, a dataset was created of about 14,000 GBM and 
12,000 meningioma images.  The final proposed DDN could classify the GBM images with 86% 
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accuracy while outperforming other methods such as SVM classifier applied on manual feature 
extraction, pre-trained networks, and shallow CNNs. 
34 
 
We have previously developed an architecture to classify CLE images from experimental brain 
gliomas into three classes: tumor tissue, injured brain cortex tissue (no tumor) and normal brain 
cortical tissue. 
36
 This study was undertaken to examine the ability of CLE image analysis to 
discriminate between tumor tissue, tissue subjected to the minor tissue trauma that surgical 
resection produces, and normal brain tissue. FNa may extravasate in the first two situations 
potentially causing surgeon confusion. This classification model was inspired by Inception, 
which is a DCNN for classifying generic images.
37
 Due to the small size of our training dataset 
(663 diagnostic images selected from 1,130 images acquired), we used fine-tuning to train the 
model with a learning rate of 0.001. We used a nested left-out validation method to estimate the 
model performance on images from new biopsies. Images were divided into 3 data sets based on 
biopsy level: training (n=446), validation (n=217), and test set (n=40).  Model performance 
increased to 88% when images were classified using 2 classes only (tumor tissue or non-tumor 
tissue) which was only slightly lower than the neuropathologists' mean accuracy (90%). The 
sensitivity and specificity of the model in discriminating a tumor region from non-tumor tissue 
were 78% and 100%, respectively. The Area Under the ROC Curve (AUC) value for tumor/non-
tumor tissue classification was 93%. Subgroup analysis showed that the model could 
discriminate CLE images from tumor and injury with 85% accuracy (mean of accuracy for 
neuropathologists was 88%), 78% sensitivity and 100% specificity. We expect that performance 
of the model will be improved in terms of accuracy and speed by going forth from a small 
experimental data set to operation on large clinical data sets. 
 
Diagnostic image classification 
 
Entropy-based filtering is one of the simplest ways to filter out non-diagnostic CLE images. In a 
study by Kamen, et al.
21
, CLE images obtained from brain tumors were classified automatically. 
An entropy-based approach was used to remove the noninformative images from their dataset 
and two common brain tumors (meningioma and glioma) were differentiated using bag of words 
and other sparse coding methods. However, entropy might not be an ideal method since many 
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nondiagnostic images have nearly as high entropy as diagnostic ones, as shown in Figure 3. Due 
to the large number of CLE images produced during surgery, importance of data pruning, as has 
been shown in our previous study
36
, and the incompetency of entropy method, we developed a 
deep learning model for reliable classification of images into diagnostic and non-diagnostic 
categories
20
. A blinded neuropathologist and 2 neurosurgeons proficient with CLE image 
interpretation individually annotated all the images in our dataset. For each patient, the 
histopathological features of corresponding CLE images and H&E-stained frozen and permanent 
sections were reviewed and the diagnostic value of each image was examined. When a CLE 
image revealed any clear identifiable histopathological feature, it was labeled as diagnostic; 
otherwise it was labeled as nondiagnostic
12
. Table 1 provides the composition of our dataset. We 
tested the developed diagnostic frame detection models on 4,171 CLE images chosen from 
various patients isolated during training.  
 
Aiming to improve the diagnostic image classification method, we then developed 42 new 
models, which included 30 single, and 12 ensemble models using two network architectures, 
three training regimes, and two ensemble methods
20
. During training of each single model, 
different sections of the dataset were used to reflect the diversity of training data in the 
developed models’ knowledge. We exercised various training regimes to investigate how ߧdeepߨ 
the training should be for CNNs applied to a CLE image classification problem to produce 
optimal (i.e., diagnostically useful) results. Depending on which layers of the network are being 
learned through training, we had three regimes. In the deep training (DT) regime, the whole 
model parameters were initialized randomly (training from scratch) and were updated through 
training. In the shallow fine-tuning (SFT) regime, the whole model weights, except the last fully 
connected layer, were initialized with the corresponding values from the pretrained model and 
their values were fixed during training. The last fully connected layer was initialized randomly 
and was tuned during training. In the deep fine-tuning (DFT) regime, all model weights were 
initialized with the corresponding values from the pretrained model and were tuned with nonzero 
learning rates. Our cross validation showed SFT and DFT experiments required 10 times smaller 
initial learning rates (0.001) compared to the DT regime (0.01). We also used a dropout layer 
(ratio = 0.5) and L2 regularization (λ = 0.005).  
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For this interobserver study, we created a validation review dataset consisting of 540 images 
randomly chosen from the test dataset in the second review. Two new neurosurgeons reviewed 
the validation review dataset without having access to the corresponding H&E-stained slides and 
labeled them as diagnostic or nondiagnostic. The ensemble of DCNN models for detecting 
diagnostic CLE images achieved 85% agreement with the gold-standard defined by the trained 
expert with subsequent confirmation by another independent observer (Figure 4), without 
considering or comparison to the H&E slide images. In comparison, the two trained 
neurosurgeons achieved 75% and 67% agreement with the gold-standard using only CLE 
images. These results indicated that when only CLE images were provided, the model could 
detect the diagnostic CLE images with better agreement to the H&E-aided annotation. The 
example CLE images assessed with our diagnostic analysis model are presented on Figure 5. In 
order to compare the power of deep learning models with filtering approaches used in other 
related studies, we used entropy as a baseline
21,33
. Subsequent evaluation of our test dataset of 
CLE images suggested that DCNN-based diagnostic evaluation has a higher agreement with the 
ground truth compared to the entropy-based quality assessment (Table 2). 
 
Feature localization and image segmentation 
 
Most of the current object localization studies in medical imaging use supervised learning that 
requires an annotated dataset for the training process. Physicians need to review the images and 
mark the location of interesting areas for each image, thus making it a costly and time-
consuming process. Weakly supervised localization (WSL) methods have been proposed in 
computer vision to localize features using a weaker annotation, i.e., image-level labels instead of 
pixel-level labels.  
 
We have previously investigated feature localization on brain tumor CLE images.
20
 Following 
the training and testing of the DCNN model for diagnostic image classification, 8 out of 384 
reviewed colored neuron activation maps from the first layer of the model were selected for 4 
diagnostic CLE images representative for glioma. Selected activation maps highlighted 
diagnostic tissue architecture patterns in warm colors. Particularly, selected maps emphasized 
regions of optimal image contrast, where hypercellular and abnormal nuclear features could be 
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identified, and could serve as diagnostic features for image classification (Figure 5, bottom row). 
Additionally, a sliding window method was successfully applied to highlight diagnostic 
aggregates of abnormally large malignant glioma cells and atypically hypercellular areas
20 
(Figure 5). Such feature localization from the hidden layers makes the interpretation of the model 
results more illustrative and objective, especially from a clinical point of view where diagnosis 
cannot be made without sufficient evidence. Additionally, model-based feature localization can 
be performed considerably faster than human inspection and interpretation. 
 
In another study, we applied a state of the art WSL approach
38
 to localize glioma tumor features 
in CLE images
39
. In this method, a global average pooling (GAP) layer was stacked to the 
convolutional layers of the network to create diagnostic feature maps. Representative localization 
and segmentation results are shown in Figures 6 and 7. A neurosurgeon with expertise in CLE 
imaging identified and highlighted the cellular areas in each CLE image (first column of both 
figures). By inserting the images and their labels (i.e., overall diagnostic quality: diagnostic and 
nondiagnostic) to the network, the model automatically learns the primary diagnostic features of 
gliomas (e.g., cellular areas). In Figure 6, the first column shows three CLE images along with 
the annotated diagnostic areas (red arrows) by a neurosurgeon, while the second column presents 
the diagnostic areas that the model highlighted with warm colors. The color bar near to each 
intensity map shows the relative diagnostic value for each color -- red marks the most diagnostic 
regions and blue marks the nondiagnostic regions. In Figure 7, after producing the diagnostic 
feature maps, each image was then segmented into diagnostic and nondiagnostic regions by 
thresholding (highlighted in green and purple); the recognized diagnostic regions correlated well 
with the neurosurgeon’s annotation. This method has two potential benefits: 1) improvement of 
the efficiency of glioma CLE imaging by recognizing the present diagnostic features and guiding 
the surgeon in tumor resection; and, 2) further investigation of the detected diagnostic regions 
may extend the physician’s perceptions about the glioma appearance and its phenotypes in CLE 
images. 
 
Deep learning-empowered CLE diagnostics in other cancers 
 
Oral squamous cell carcinoma 
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Oral squamous cell carcinoma (OSCC) is a common cancer affecting 1.3 million cases 
worldwide annually
40
. Because of the insufficient precision in current screening methods, most 
OSCC cases are unfortunately diagnosed at advanced stages leading to poor clinical outcome. 
CLE has allowed in vivo examination of OSCC which may lead to earlier and more effective 
therapeutic outcomes during examination
41
. In a study by Aubreville, et al.
42
, a CNN was trained 
to classify normal and carcinogenic CLE image patches. A dataset of 11,000 CLE images was 
evenly distributed between the two classes. The images were acquired from 12 patients and 
images with artifact (motion, noise, mucus or blood) were excluded, leading to 7,894 good 
quality images.  Consequently, each image was divided into 21 overlapping patches, all of which 
were labeled the same as the whole image. The artifact patches were removed from images and 
the remaining ones were normalized to have zero mean and unit standard deviation. Image 
rotation was used to augment the image dataset size. 
 
LeNet was used to train the model for patch classification. This network has only two 
convolutional and one fully connected layers with drop out. The model combined the probability 
scores from each constituent patch as being carcinogenic to arrive at the final prediction for the 
whole image. The network was trained from scratch with initial learning rate of 0.001 and Adam 
optimizer to minimize the cross-entropy. 
 
To compare the proposed method with conventional textural feature-based classification 
approaches, two feature extraction methods (Gray-Level Co-occurrence Matrix (GLCM) and 
Local Binary Patterns (LBP)) and a classification approach (Random Forest (RF)) methods were 
combined to discriminate images at two scales (1.0 x and 0.5 x). Furthermore, CNN transfer 
learning was explored by shallow fine-tuning the last fully connected layer of the pretrained 
Inception-v3 network
43
, using the original dataset. For cross validation, a leave-one-patient-out 
cross validation was followed, meaning images were used from one patient for testing the model 
and the remaining cases for training the model. 
 
Both the patch-based and whole image CNN approaches outperformed the textural feature 
extraction and classification methods. The proposed CNN method could differentiate the normal 
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and carcinogenic CLE images with 88% accuracy, 87% sensitivity and 90% specificity when 
applied at 0.5x scale (the 1x scale produced suboptimal results). The shallow fine-tuned 
Inception-v3 model could also achieve 87% accuracy, 91% sensitivity and 84% specificity. The 
AUC values for the two methods (the proposed CNN and Inception-v3) were roughly similar 
(95%). The AUC values for feature extraction methods and RF classifier was significantly lower 
than CNN methods (RF-GLCM = 81%, RF-LBP = 89%). Interestingly, the trained model on 
OSCC CLE images was successfully applied for classification of CLE images from a different 
organ site, vocal cord squamous cell carcinoma. 
 
In transfer learning with pretrained Inception-v3 the authors only modified the weights of the last 
layer, while keeping the previous layers parameters stationary. However, studies
20,44
 have shown 
that deeply fine-tuning the pretrained networks may help the network adapt better to the new 
dataset by upgrading the feature extraction layers as well. However, shallow fine tuning only 
allows updating the classification layer, which might not be sufficient for optimal performance. 
 
Vocal cord cancer 
 
To differentiate between healthy and cancerous tissue of vocal cords, Vo, et al.
45
 developed a 
Bag of Words (BoW) based on textural and CNN features using a dataset of 1,767 healthy and 
2,657 carcinogenic images from five patients. Small patches with 105x105 pixel size were 
extracted and augmented (with rotation), leading to 374,972 patches. For the textural feature-
based classification, each image was represented by the concatenation of all its constituent patch-
driven feature descriptors. For the CNN features, a LeNet shallow CNN was trained on the patch 
dataset for a binary classification (with SGD optimizer; momentum = 0.9 and learning rate = 
0.0005). To create the visual vocabulary, two feature encoding (Fisher vector
46
 and Vector of 
Locally Aggregated Descriptors (VLAD)
47
) and two classification methods (SVM and RF) were 
tested for comparing their classification performance. 
 
A Leave-One-Sequence-Out (LOSO) cross-validation was used to evaluate these methods. The 
CNN features combined with VLAD encoder and RF classifier achieved an accuracy of 82% and 
sensitivity of 82% on the test images that surpassed other approaches. However, despite its 
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promising accuracy, the proposed multi-stage approach (patch creation, feature extraction, 
feature encoding, clustering and classification) is much more complicated than the current end-
to-end DCNN architectures, which have all these procedures embedded in their stacked layers. 
However even with this approach, the CNN features could outperform textural features extracted 
manually
45
. 
  
Lung cancer 
 
Gil, et al.
48
 investigated visual patterns in bronchoscopic CLE images for discriminating benign 
and malignant lesions and aiding lung cancer diagnosis. A pretrained network developed by the 
Visual Geometry Group (VGG)
49
 on a large generic image dataset was used for feature 
extraction and reduced the resulting feature vector dimension from 4,096 to 100, while 
preserving roughly 90% of the original feature vector energy for computational efficiency. Three 
different methods (k-Means, k-Nearest Neighbor (kNN), and their proposed topology-based 
approach) were applied on the feature codes to group images with similar features together and 
intrinsically discriminate images from benign and malignant tissue. Model predictive power was 
compared with the final diagnosis on 162 images from 12 cases (6 with malignant and 6 with 
benign lesions) and achieved 85% accuracy, 88% sensitivity, and 81% specificity. 
 
Inter-observer studies were performed with three observers to compare the subjective visual 
assessment of images with the model performance (the observers were blinded to the final 
diagnosis). Interestingly, the three observers could make a correct diagnosis only for 60% of the 
selected CLE images (sensitivity: 73% for malignant and 36% for benign images) on average. In 
the second experiment, two observers made a final diagnosis after examining all the images from 
each case. The model was also supplied with all the images from each of the 12 cases and 
rendered a final decision for each case. While the model could differentiate malignant and 
benign cases with 100% accuracy (12/12), the two observers could confirmatively make the 
correct diagnosis only in 67% (8/12) of cases. 
 
Although the observers’ knowledge in the domain might have affected their performance, the 
objective results suggest that the bronchoscopic CLE images contain enough visual information 
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for determining the malignancy of the tumor and the VGG network is an excellent candidate for 
extracting these discriminative features. The proposed topology-based clustering method could 
outperform common clustering and classification methods (K-means and kNN) in differentiating 
the two classes of images. 
 
Despite its advantages, the proposed method had two major limitations. First, even though it can 
differentiate images from the two classes, it cannot predict the label for each cluster. The method 
can separate the images into two groups, but it is not able to give information about their labels. 
Second, it is unclear if there was independent development (for determining model parameters) 
and test datasets to avoid bias in model development. 
 
Gastrointestinal tract cancer 
  
Hong, et al.
50
 proposed a CNN architecture for classifying CLE images from three subcategories 
of Barret's esophagus: intestinal metaplasia (IM), gastric metaplasia (GM), and neoplasia (NPL). 
The network was composed of four convolutional layers and two max-pooling and fully 
connected layers. The size of convolutional kernels was 3x3 and zero padding was also used. 
Stride of max-pooling was 2x2 which was applied in layers two and four. Fully connected layers 
followed the fourth convolutional layer, and each had 1,024 neurons. The output label was 
determined by a softmax layer which produced 3 probabilities for each subcategory. 
 
The network was trained on the augmented CLE images of Barret's esophagus (155 IM, 26 GM 
and 55 NPL) for 15,000 iterations with the batch size of 20 images. Cross-entropy was used as a 
cost function in their experiment. The trained model was then tested on 26 independent images 
(17 IM, 4 GM and 5 NPL) for validation. The imbalance in size of different subcategories caused 
the model to observe more frequent instances of IM and NPL compared to GM during training. 
This created a bias in the model prediction which can be seen in the high accuracy for predicting 
IM and NPL instances (100% and 80%) and very low accuracy for predicting GM instances 
(0%). However, CLE is being used with increasing frequency for detecting pre-cancerous and 
cancerous lesions in the gastrointestinal (GI) tract. The highest numbers of CLE images have 
been acquired from the GI tract where such imaging technology has been approved for use 
17 
 
clinically for a few years. 
 
Conclusions 
 
Precision, personalization, and improved therapeutics in medicine can only progress with 
improved technology, analysis, and logic. The science and philosophy of theranostics is the 
nexus of these. Several studies have emphasized the importance of  theranostic imaging in 
personalized treatment of cancer
25ߞ27
. Medical data acquired on patients has become more 
voluminous, and it will continue in such manner. The amount of data available and necessary for 
analysis has already eclipsed human capabilities. For example, the new technology of handheld 
surgical tools that can rapidly image at the cellular resolution on-the-fly produces more images 
than a pathologist can possibly examine. As CLE technology develops, there will not be one 
fluorophore, but multiple fluorophores applied directly to the tumor or administered to the 
patient varying from nonspecific to specifically identifying cell structures or processes used 
simultaneously and presented in a myriad of image combinations for greatly varying 
histopathology. Analytic methods for selection and interpretation of the CLE images is already 
being explored to be incorporated into CLE operating systems so that the unit display can 
differentiate tissue and label the image as well with near-on-the-fly capabilities. Computational 
hardware power and effective analytic model infrastructure are the only two limits. CLE systems 
and other related systems are being produced by several imaging technology companies and 
groups and are close to approval with European and American medical device regulatory 
agencies. However, it seems prudent given the enormous numbers of images already produced 
and those projected with adoption of such technology, that there is immediate exploration into 
such image analysis methods to allow the pathologist and neurosurgeon to make optimal 
decisions based on the CLE imaging, and to take advantage of the on-the-fly technology 
proposition. 
 
Success or meaningful diagnostic and therapeutic indication in the burgeoning field of 
theranostics is only as good as the data incorporated and the methodology employed for analysis 
and to extract meaning, including its validation. In many cases relatively simple statistics have 
been used for analysis, while pattern recognition or neural network techniques may be used in 
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more complicated scenarios. For images such as from CLE, the whole image may be important, 
or perhaps only certain subregions, or crucial data may lie in regions on cursory inspection 
deemed to be nonuseful, such as in areas of motion artifact. Complicating this situation are the 
overwhelming numbers of images yielded from the CLE application. Clinical decision 
environments currently require assistance to not only access and categorize the collection of 
images, but to also draw conclusions and inferences that have critical diagnostic and treatment 
consequences. A pathologist and neurosurgeon will not have time to inspect a thousand images 
per case, especially in the midst of CLE use intraoperatively. Therefore, a theranostics approach, 
i.e., the nexus of biological data, rapid informatics scrutiny and evaluation, and tailored human 
decision, must be employed as we venture into realms of ever increasing information in 
neurosurgery in search of personalization and precision, especially as we have encountered it 
first in the surgery and treatment of malignant invasive brain tumors. Additionally, pathologists 
and neurosurgeons will need to become versed in the methodology of the CLE decision making 
processes to have confidence in diagnostic labels and to base treatment decisions upon them, 
thus the reason for presenting details of analytical architectures in this review. 
 
Two DCNN based approaches are reviewed in this paper: models that can automatically classify 
CLE images (classifications of images that are diagnostic/nondiagnostic
20
, glioma/nonglioma
19
, 
tumor/injury/normal
36
) and models that can localize histological features from diagnostic images 
using weakly supervised methods
39
. Manually annotated in-house datasets were used to train and 
test these approaches in most of the studies. For the tumor classification purpose, data pruning 
could enhance the results for both DCNN models and outperformed manual feature extraction 
and classification
21
. Fine-tuning and ensemble modeling could enhance the model performance 
in the diagnostic image classification. The ensemble effect was stronger in DT and DFT than 
SFT developed models. 
 
Despite extensive research on CLE clinical application in neurosurgery
9ߞ14,18
, there have been 
few attempts in the automatic analysis of these images to enhance CLE clinical utility.  Deep 
learning could be beneficial in filtering the nondiagnostic images with higher speed and 
reasonable accuracy compared to subjective assessment.
19
 Our inter-rater agreement evaluation
20
 
showed that the proposed model could achieve promising agreement with the gold-standard 
19 
 
defined by a majority assessment by neurosurgeon reviewers. Overall, results suggest that 
DCNN-based diagnostic evaluation has a higher agreement with the ground truth than the 
entropy-based quality assessment used in other studies
21,33
. Furthermore, such methods suggest 
that semantic histological features may be highlighted in CLE images as confirmed by a 
neurosurgeon reviewer. This shows that the DCNN structure could learn semantic concepts like 
tumor type or diagnostic value of CLE images through different levels of feature representation. 
Early results show that WSL-based glioma feature localization was able to precisely mark the 
cells in the images. DCNNs are also much faster than handcrafted methods at deployment phase. 
Our deeply trained models could classify about 40 new images in a second, while the 
handcrafted method takes 5.4 seconds to process single image
21
. 
 
Other confocal imaging techniques may be aided by such deep learning models. Confocal 
reflectance microscopy (CRM) has been studied
51,52
 for rapid, fluorophore-free evaluation of 
brain biopsy specimen ex vivo. CRM allows preserving the biopsy tissue for future permanent 
analysis, immunohistochemical studies, and molecular studies. Proposed DCNN classification 
and localization approaches are well-suited for analysis and interpretation of CRM images as 
well as CLE. Further studies on application of DCNN on CRM images are needed to further 
validate their utility for intraoperative diagnosis.  
 
Continued use of unsupervised image segmentation methods to detect meaningful histological 
features from confocal brain tumor images will likely allow for more rapid and detailed 
diagnosis. With the large rate of images produced, a technology-free and unassisted approach to 
analyze the CLE images would impede the exploitation of maximal pathological information 
during surgery. Accessible databases of CLE images would allow various image analysis 
methods to be tried on large numbers of images. Such image collection strategies are part of the 
platform of the relatively new International Society for Endomicroscopy. DCNNs can enhance 
extraction and recognition of CLE diagnostic features that may be integrated into the standard 
brain tumor classification protocols similarly to the current research flow in the whole-slide 
digital image analysis for personalized cancer care
53,54
. This may refine current diagnostic 
criteria and potentially aid the discovery of novel related features. With such technology, 
neurosurgery truly enters the realm of theranostics in the operating room itselfߟwe are on the 
20 
 
verge of highly tailored and precise surgery at the cellular level. Such an approach is critical for 
neurosurgery because surgery and treatment for an invasive brain tumor frequently deals with 
spread into eloquent cortex ߞ the areas that make us ߧhuman.ߨ In fact, even before entering the 
operating room the neurosurgeon can begin to discuss strategy with the patient if tumor is 
located or not located in eloquent cortex based on a CLE ߧoptical biopsyߨ. Thus, theranostics 
also involves treatment strategies and decisions of when to ߧstopߨ, especially true when the CLE 
system intraoperatively reveals cells invading for example primary motor or language cortex. 
With analytical pathologists uniting different clinical and morphological information for an 
integrated diagnosis, such a computer-aided CLE analysis workflow would improve imaging 
(diagnostics) and achieve maximal, more precise removal of tumor mass (therapy) as the initial 
treatment goals toward greater precision, personalization and success in the surgery and 
treatment of malignant invasive brain tumors (theranostics). 
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FIGURE CAPTIONS 
 
Figure 1. Representative Confocal Laser Endomicroscopy (CLE) images from glioma and 
meningioma acquired with Optiscan 5.1, Optiscan Pty., Ltd. (a) anaplastic oligodendroglioma, 
(b) recurrent astrocytoma, (c) glioblastoma multiforme (GBM), (d) fibrous meningioma (grade 
I), (e) chordoid meningioma (grade II), (f) atypical meningioma (grade II). Field of view = Ͷ7ͷ × Ͷ7ͷµm, resolution = ͳͲʹͶ × ͳͲʹͶ pixels, bar = 100 µm.  (Glioblastomas are a brain 
malignancy of astrocytic cell origin, show wild pleomorphism, proliferation of abnormal tumor-
associated vasculature, necrosis, and vast brain invasion. Meningiomas arise from 
meningothelial cells and are usually attached to the dura. Although of a common origin, 
meningiomas have histological pattern subtypes and more aggressive types show atypical or 
anaplastic features. They do not display malignant brain infiltration.
55
) 
 
Figure 2. Deep convolutional neural network (DCNN) architecture. A schematic diagram of 
AlexNet
56
, a famous DCNN architecture that was trained on CLE images for diagnostic 
classification by Izadyyazdanabadi et al.
20
, is shown in (a). Different feature maps of the first 
convolutional layer (color images) were calculated by convolving different filters (red squares) 
with the corresponding regions of the input image (illustrated in (b)). 
 
Figure 3. Entropy of diagnostic (orange) and nondiagnostic (blue) images. The overlap between 
the entropy of diagnostic and nondiagnostic CLE frames limits its feasibility for precise 
discrimination between the two classes
19
. 
 
Figure 4. A schematic diagram of interobserver study. Gold standard was defined using the 
initial review and one of the secondary raters. The agreement of the ensemble model as well as 
the other rater with the gold standard is calculated
20
. 
 
Figure 5. Unsupervised semantic localization of the CLE histopathological features20. First row 
displays the original CLE images, along with the probability of each image being diagnostic (D) 
and nondiagnostic (ND), estimated by the model. Red arrows mark the cellular regions 
recognized by a neurosurgeon. Second row shows the corresponding activation of neurons from 
the first layer (conv1, neuron 24) (shallow features learned by the model); it highlights some of 
the cellular areas (in warm colors) present in the images which were identified as diagnostic 
regions by the neurosurgeon reviewer. The color bars show the relative diagnostic value for each 
color: red marks the most diagnostic regions (1.0) and blue marks the nondiagnostic regions 
(0.0). Field of view = Ͷ7ͷ × Ͷ7ͷµm, resolution = ͳͲʹͶ × ͳͲʹͶ pixels, bar = 100 µm. 
 
Figure 6. Histological glioma feature localization with a weakly supervised approach: global 
average pooling (GAP)
39
. Left column shows CLE images from glioma cases ((a, c) recurrent 
infiltrating astrocytoma (e) oligodendroglioma). Red arrows mark the cellular regions recognized 
by a neurosurgeon. Second column shows the important regions detected with the model 
(highlighted in warm colors). The color bars show the relative diagnostic value for each color: 
red marks the most diagnostic regions (1.0) and blue marks the nondiagnostic regions (0.0). Field 
of view = Ͷ7ͷ × Ͷ7ͷµm, resolution = ͳͲʹͶ × ͳͲʹͶ pixels, bar = 100 µm. 
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Figure 7. Diagnostic image segmentation in CLE images of gliomas with GAP approach39. First 
column (a, d, e) shows the original diagnostic images from glioma cases ((a) recurrent GBM, (d) 
recurrent infiltrating astrocytoma, (e) anaplastic oligodendroglioma). Red arrows mark the 
cellular regions recognized by a neurosurgeon. Second column shows the segmented key 
features highlighted in purple. Field of view = Ͷ7ͷ × Ͷ7ͷµm, resolution = ͳͲʹͶ × ͳͲʹͶ pixels, 
bar = 100 µm. 
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TABLES 
 
Table 1. The composition of our dataset in the diagnostic image classification20. Number of 
patients and images used for model development and testing is provided. 
 
 Development Test Total 
No. of Patients 59 15 74 
No. of Images 16,366 4,171 20,537 
No. of Diagnostic Images 8,023 2,071 10,094 
No. of Nondiagnostic Images 8,343 2,100 10,443 
 
 
 
Table 2. DCNN and entropy-based performance in diagnostic image classification20. DCNN 
methods showed higher agreement with the neurosurgeons’ evaluation. DCNN237 has a deeper 
architecture with fewer parameters than DCNN1
56
. 
 
Model Accuracy (%) AUC 
DCNN 1 78.8 0.87 
DCNN 2 81.8 0.89 
Entropy-based 57.20 0.71 
 
 
